BRPI0414916A - métodos para a preparação de compostos de sulfonamida de benzoxazol e intermediários dos mesmos - Google Patents

métodos para a preparação de compostos de sulfonamida de benzoxazol e intermediários dos mesmos

Info

Publication number
BRPI0414916A
BRPI0414916A BRPI0414916-5A BRPI0414916A BRPI0414916A BR PI0414916 A BRPI0414916 A BR PI0414916A BR PI0414916 A BRPI0414916 A BR PI0414916A BR PI0414916 A BRPI0414916 A BR PI0414916A
Authority
BR
Brazil
Prior art keywords
methods
sulfonamide compounds
benzoxazole sulfonamide
preparation
intermediates
Prior art date
Application number
BRPI0414916-5A
Other languages
English (en)
Inventor
Herman Augustinus De Kock
Walter Ferdinand Mari Filliers
Wim Albert Alex Aelterman
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of BRPI0414916A publication Critical patent/BRPI0414916A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"MéTODOS PARA A PREPARAçãO DE COMPOSTOS DE SULFONAMIDA DE BENZOXAZOL E INTERMEDIáRIOS DOS MESMOS". A presente invenção refere-se aos métodos para a preparação de compostos de sulfonamida de benzoxazol da fórmula (9) como também intermediários novos da fórmula (6) para o uso no referido método. Mais em particular a invenção refere-se aos métodos para a preparação de compostos de sulfonamida de 2-amino-benzoxazol que fazem uso dos intermediários de sulfonamida de 2-mercapto-benzoxazol, mais em particular métodos que empregam o intermediário de éster 1-benzil-2-hidróxi-3-¢isobutil(2metilsulfanil-benzoxazol-6-sulfonil)-amin o)-propil)-carbâmico e aos métodos tratáveis em escala industrial. Os ditos compostos de sulfonamida de benzoxazol são particularmente úteis como inibidores de HIV protease. Os substituintes são definidos nas reivindicações.
BRPI0414916-5A 2003-09-30 2004-09-30 métodos para a preparação de compostos de sulfonamida de benzoxazol e intermediários dos mesmos BRPI0414916A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03103630 2003-09-30
US50799603P 2003-10-02 2003-10-02
PCT/EP2004/052382 WO2005030739A1 (en) 2003-09-30 2004-09-30 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof

Publications (1)

Publication Number Publication Date
BRPI0414916A true BRPI0414916A (pt) 2006-11-07

Family

ID=34395298

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414916-5A BRPI0414916A (pt) 2003-09-30 2004-09-30 métodos para a preparação de compostos de sulfonamida de benzoxazol e intermediários dos mesmos

Country Status (24)

Country Link
US (1) US20070123574A1 (pt)
EP (1) EP1670773B1 (pt)
JP (1) JP4919802B2 (pt)
KR (1) KR101090102B1 (pt)
CN (1) CN1860107B (pt)
AP (1) AP1985A (pt)
AT (1) ATE353323T1 (pt)
AU (1) AU2004276017B2 (pt)
BR (1) BRPI0414916A (pt)
CA (1) CA2537877C (pt)
DE (1) DE602004004674T2 (pt)
DK (1) DK1670773T3 (pt)
EA (1) EA011891B1 (pt)
ES (1) ES2281828T3 (pt)
IL (1) IL173891A0 (pt)
IN (1) IN2012DN02301A (pt)
MX (1) MXPA06003575A (pt)
NO (1) NO20061951L (pt)
NZ (1) NZ546279A (pt)
PL (1) PL1670773T3 (pt)
PT (1) PT1670773E (pt)
SI (1) SI1670773T1 (pt)
WO (1) WO2005030739A1 (pt)
ZA (1) ZA200602603B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
WO2011044134A1 (en) * 2009-10-05 2011-04-14 Albany Molecular Research, Inc. Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof
CA2823955A1 (en) 2011-01-19 2012-07-26 Albany Molecular Research, Inc. Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
DE69625183T2 (de) * 1995-03-10 2003-10-09 Searle & Co Heterocyclocarbonyl-aminosäure-hydroxyethylamino-sulfonamid inhibitoren retroviraler proteasen
EP0861249A1 (en) * 1995-11-15 1998-09-02 G.D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
CA2372352A1 (en) * 2000-04-07 2001-10-18 Hyun-Gyu Park Sulfonamide derivative as a matrix metalloproteinase inhibitor
US6455738B1 (en) * 2000-07-13 2002-09-24 Rhodia Chimie Process for the sulfonation of an aromatic compound
MXPA03007236A (es) * 2001-02-14 2003-12-04 Tibotec Pharm Ltd 2-(amino sustituido)-benzotiazol sulfonamidas inhibidoras de proteasa de vih de amplio espectro.
AR035970A1 (es) * 2001-05-11 2004-07-28 Tibotec Pharm Ltd 2-amino-benzoxazol sulfonamidas inhibidoras de amplio espectro de la hiv proteasa, composicion farmaceutica, metodo "in vitro" para inhibir la replicacion retroviral, y utilizacion de estos compuestos en la manufactura de medicamentos
AR037797A1 (es) * 2001-12-12 2004-12-01 Tibotec Pharm Ltd Combinacion de inhibidores de proteasa dependientes del citocromo p450
MY142238A (en) * 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors

Also Published As

Publication number Publication date
NO20061951L (no) 2006-05-02
JP4919802B2 (ja) 2012-04-18
ATE353323T1 (de) 2007-02-15
IL173891A0 (en) 2006-07-05
AU2004276017A1 (en) 2005-04-07
DK1670773T3 (da) 2007-05-29
JP2007507468A (ja) 2007-03-29
KR101090102B1 (ko) 2011-12-07
CN1860107B (zh) 2013-08-21
ES2281828T3 (es) 2007-10-01
KR20060092224A (ko) 2006-08-22
AU2004276017B2 (en) 2010-08-19
EA200600699A1 (ru) 2006-08-25
US20070123574A1 (en) 2007-05-31
NZ546279A (en) 2008-09-26
IN2012DN02301A (pt) 2015-08-14
AP2006003603A0 (en) 2006-04-30
PL1670773T3 (pl) 2007-06-29
DE602004004674T2 (de) 2007-11-22
ZA200602603B (en) 2008-05-28
WO2005030739A1 (en) 2005-04-07
EP1670773B1 (en) 2007-02-07
CN1860107A (zh) 2006-11-08
EA011891B1 (ru) 2009-06-30
CA2537877C (en) 2015-03-17
CA2537877A1 (en) 2005-04-07
EP1670773A1 (en) 2006-06-21
PT1670773E (pt) 2007-05-31
SI1670773T1 (sl) 2007-06-30
MXPA06003575A (es) 2006-06-05
AP1985A (en) 2009-03-30
DE602004004674D1 (de) 2007-03-22

Similar Documents

Publication Publication Date Title
BR0215493A (pt) Processo para preparação de ésteres escopìnicos
DK1789398T3 (da) 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE)
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
BR0307299A (pt) Anticolinérgicos, processo para sua preparação bem como seu uso como medicamento
ECSP077271A (es) Derivados de pirimidina
BRPI0615029A2 (pt) processos e intermediários
BRPI0514361A (pt) processo para a produção de dihidropteridinonas
ECSP077259A (es) Derivados de pirimidina
EA200401157A1 (ru) N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv
BR0314113A (pt) Derivados de amino propanol
AR052866A1 (es) Fenil-metanonas monociclicas sustituidas
BR0110998A (pt) Derivados de fenilglicina
BRPI0510743A (pt) processo para a preparação de entecavir e intermediários dos mesmos mediante oxidação de carbono-silìcio e composição quìmica
HRP20050352A2 (en) Piperazinyl and diazapanyl benzamides and benzthioamides
HRP20040690B1 (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
BRPI0506718A (pt) compostos, processo de preparação dos mesmos, e, composição farmacêutica ou cosmética
NO20053089D0 (no) Carbamidsyreestere med anticolinergisk virkning.
EA199900279A1 (ru) Производные бензамида и их применение в качестве лекарственных средств с лтв4-антагонистической активностью
BRPI0415203A (pt) pentanóis reestruturados, um processo para sua produção e seu uso como agentes antiinflamatórios
UY29892A1 (es) Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
PE20050473A1 (es) Nuevos derivados de pirimidin-2-amina
BR0215709A (pt) Processo para a preparação de cefdinir
AR016175A1 (es) Compuestos derivados del acido dihidroxihexanoico, su uso para la preparacion de medicamentos y composiciones de los mismos.
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их
BR0312593A (pt) Aciluréias substituìdas por uréia e uretano, processo para a sua produção e sua aplicação

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: C07D 263/58, C07D 413/12, C07D 417/12, A61P 31/18

Ipc: C07D 263/58 (2011.01)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.